From their genetic KO screen, they identified Dynein light chain 1 (DYNLL1) loss as a major driver of platinum resistance and of PARP inhibitor resistance in BRCA1 null ovarian cancer cell lines. Here, BRCA1 is linked to ovarian cancer.